Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients

Transplantation

Volumn 63, Issue 7, 1997, Pages 1034-1036

  Bursztyn, Michael ^a   Zelig, Orly ^a   Or, Reuven ^a   Nagler, Arnon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; ISRADIPINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT REJECTION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIHYPERTENSIVE AGENTS; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; ISRADIPINE; MALE; PILOT PROJECTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030984385     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704150-00025     Document Type: Article

References (10)

1. Loughran TP, Deeg HJ, Dahlberg S, Kennedy MS, Storb R, Thomas ED. Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft versus host disease prophylaxis. Br J Haematol 1985; 59: 547.
2. June CH, Thompson CB, Kennedy MS, Loughran TP, Deeg HJ. Correlation of hypomagnesemia with onset of cyclosporine-associated hypertension in marrow transplant patients. Transplantation 1986; 41: 47.
3. Kone BC, Whelton A, Santos G, Saral R, Watson AJ. Hypertension and renal dysfunction in bone marrow transplant recipients. Q J Med 1988; 69: 985.
4. Textor SC, Forman SJ, Bravo EL, Carlson J. De-novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients. Transplant Proc 1988; 20 (suppl 3): 480.
5. Porter GA, Bennett WM, Sheps SG. Cyclosporine-associated hypertension. National High Blood Pressure Education Program. Arch Int Med 1990; 150: 290.
6. Textor SC, Canzanello VJ, Taler SJ, et al. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994; 69: 1182.
7. Davidson I, Rooth P, Fisher D, et al. Verapamil ameliorates acute cyclosporine A nephrotoxicity and improves immunosuppression after cadaver renal transplantation. Transplant Proc 1989; 21: 1511.
8. Berg K, Holdaas E, Endersen L, Fauchald P, Bran T, Solbu D. Effects of isradipine on renal function in cyclosporine-treated transplanted patients. Nephrol Dial Transplant 1991; 6: 725.
9. Staessen JA, O'Brien ET, Atkins N, Audry AK. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens 1993; 11: 1289.
10. Taler SJ, Tetor SC, Canzanello VJ, Wilson DJ, Weisner RH, Krom RA. Loss of nocturnal blood pressure after liver transplantation during immunosuppressive therapy. Am J Hypertens 1995; 8: 595.